Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics


The Leukemia & Lymphoma Society (LLS) is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients. Since 1949 LLS has been on the forefront of blood cancer advances such as chemotherapies and stem cell transplantation leading the way to the targeted therapies and immunotherapies that are saving thousands of lives today. LLS is changing the landscape of cancer with more than 300 active research projects that explore different avenues of new and adventurous research; ones with promise and ones that will save lives not someday, but today. MolecularMD is a proud sponsor and supporter of the annual Light The Night Walk fundraising campaign of The Leukemia & Lymphoma Society which brings together families and communities to honor blood cancer survivors, as well as those lost to the diseases, and shine a light on the importance of finding cures and providing access to treatments for blood cancer patients. Dan Snyder, President and CEO of MolecularMD, is the 2015 chairman for the Portland, OR Light the Night Walk on October 24, 2015.

MolecularMD discusses the clinical application of liquid biopsy or circulating tumor DNA (ctDNA) and its benefits within the field of oncology and companion diagnostics.